Johnson & Johnson
NYSE: JNJ
$151.87
-$1.37 (-0.9%)
Closing Price on November 14, 2024
JNJ Articles
Customers, employees, shareholders and taxpayers hate large corporations for many reasons. 24/7 Wall St. reviewed a lengthy list of corporations for which there is substantial research data to choose...
Published:
Last Updated:
Each January, 24/7 Wall St. forecasts the publicly traded U.S. companies that will have the highest profits in the year ahead. This year, Apple (NASDAQ: AAPL) is likely to pass Exxon Mobil (NYSE:...
Published:
Last Updated:
The lineup of the Dogs of the Dow, simply the ten highest dividend yield stocks of the thirty Dow Jones Industrial Average components, appears to be undergoing a bit of change for 2012. There is a...
Published:
Last Updated:
Sony (NYSE: SNE) will sell its LCD business to Samsung for $940 million. (Reuters) The yuan hits a high against the dollar and may gain 4% this year. (Reuters) Amazon.com’s (NASDAQ: AMZN) program...
Published:
Throughout December we have been giving updates on dividends that will rise in the coming days and weeks from the 30 Dow Jones Industrial Average stocks. Many have already come true and others are...
Published:
Last Updated:
Dividends are still rising and equity and income investors should expect more of the same for 2012. The Walt Disney Company (NYSE: DIS) joined in on the dividend hike brigade with another dividend...
Published:
Last Updated:
It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1 billion to fail to get the drug to market. Like the movie business, a drug company tries to develop that...
Published:
The economic choppiness is coming to a head with the age of dividend hikes. The pressure is going to remain for companies to continue returning capital to shareholders while also looking for...
Published:
Last Updated:
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of September 30, 2011. These public stock holdings have been broken...
Published:
Last Updated:
Italy and Greece begin efforts to prove that their sovereign debt is safe. (Reuters) Groupon (NASDAQ: GRPN) will make a major holiday effort to drive extra revenue. (Reuters) Appetite for Olympus...
Published:
Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better than analysts expected, but worries persist that the company will be hit...
Published:
Last Updated:
It’s that time of year again, when proxies are released and many business publications run lists of the highest paid CEOs at America’s large public companies. The compensation figures are...
Published:
Last Updated:
Today was a day of red that went to a day of green. Earnings were at first a disappointment, and producer price index came out far hotter at +0.8% on the headline number before the +0.2% reading if...
Published:
Last Updated:
Earnings season is upon us and so far things are shaping up either a bit better, or less-bad, than what the news reports and headlines might have led investors to believe. Next week is going to be...
Published:
Last Updated:
Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent new on the coming flu season, lower rates of prescription writing, and more...
Published:
Last Updated: